Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2019
Historique:
received: 13 11 2018
revised: 28 03 2019
accepted: 09 04 2019
pubmed: 21 4 2019
medline: 3 4 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

The aims of this study were: to examine regional rates of change in tau-PET uptake and grey matter volume in atypical Alzheimer's disease (AD); to investigate the role of age in such changes; to describe multimodal regional relationships between tau accumulation and atrophy. Thirty atypical AD patients underwent baseline and one-year follow-up MRI, [

Identifiants

pubmed: 31004914
pii: S2213-1582(19)30173-1
doi: 10.1016/j.nicl.2019.101823
pmc: PMC6475765
pii:
doi:

Substances chimiques

MAPT protein, human 0
tau Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

101823

Subventions

Organisme : NIA NIH HHS
ID : R01 AG050603
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Brain. 2018 Jan 1;141(1):271-287
pubmed: 29228201
PLoS One. 2015 Oct 13;10(10):e0140311
pubmed: 26461913
J Alzheimers Dis. 2016 Nov 19;55(2):465-471
pubmed: 27802224
Ann Neurol. 2015 Nov;78(5):787-800
pubmed: 26344059
J Neurosci. 2016 Jul 13;36(28):7364-74
pubmed: 27413148
Ann Neurol. 2011 Jan;69(1):181-92
pubmed: 21280088
Brain. 2017 Mar 1;140(3):748-763
pubmed: 28077397
Alzheimers Dement. 2018 Aug;14(8):1005-1014
pubmed: 29605222
Int J Epidemiol. 2000 Feb;29(1):158-67
pubmed: 10750618
Alzheimers Dement (Amst). 2018 Mar 06;10:245-252
pubmed: 29780869
Ann Neurol. 2016 Aug;80(2):247-58
pubmed: 27323247
Brain. 2017 Sep 1;140(9):2286-2294
pubmed: 29050382
Acta Neuropathol. 2014 May;127(5):667-83
pubmed: 24531916
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Ann Neurol. 2019 Feb;85(2):229-240
pubmed: 30597624
Neurobiol Aging. 2018 Mar;63:22-32
pubmed: 29220823
PLoS One. 2012;7(2):e31302
pubmed: 22312444
Neuroimage Clin. 2017 Sep 25;17:452-464
pubmed: 29159058
Hum Brain Mapp. 2019 Apr 1;40(5):1618-1631
pubmed: 30549156
Neurology. 2013 Mar 5;80(10):911-8
pubmed: 23408873
Brain. 2013 Mar;136(Pt 3):844-58
pubmed: 23358601
Brain. 2018 May 1;141(5):1517-1528
pubmed: 29538647
Lancet Neurol. 2013 Apr;12(4):357-67
pubmed: 23477989
Brain. 2008 Mar;131(Pt 3):665-80
pubmed: 18263627
JAMA Neurol. 2018 May 1;75(5):548-556
pubmed: 29435558
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
Neuroimage. 2015 Jun;113:61-9
pubmed: 25797830
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
Neurobiol Aging. 2018 Jun;66:49-58
pubmed: 29518752
Lancet Neurol. 2011 Mar;10(3):280-8
pubmed: 21185234
Neurology. 2013 Mar 5;80(10):890-6
pubmed: 23446680
Biol Psychiatry. 2010 Nov 15;68(10):879-84
pubmed: 20598287
Brain. 2009 May;132(Pt 5):1355-65
pubmed: 19339253
Lancet Neurol. 2010 Jan;9(1):119-28
pubmed: 20083042
Cereb Cortex. 2019 May 1;29(5):1997-2009
pubmed: 29912295
Med Image Anal. 2008 Feb;12(1):26-41
pubmed: 17659998
Neurology. 2008 Oct 14;71(16):1227-34
pubmed: 18633132
Brain. 2016 May;139(Pt 5):1551-67
pubmed: 26962052
JAMA Neurol. 2017 Apr 1;74(4):427-436
pubmed: 28241163
Lancet Neurol. 2012 Feb;11(2):170-8
pubmed: 22265212
Mol Psychiatry. 2018 Jul;23(7):1666-1673
pubmed: 28507319
Alzheimers Dement. 2017 Mar;13(3):205-216
pubmed: 27697430
Neurobiol Aging. 2017 May;53:103-111
pubmed: 28254589
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
Alzheimers Dement. 2012 Jan;8(1):1-13
pubmed: 22265587
Neuron. 2012 Feb 23;73(4):685-97
pubmed: 22365544
Biostatistics. 2009 Jul;10(3):515-34
pubmed: 19377034
Neuroimage. 2010 Apr 15;50(3):1004-16
pubmed: 20083207
J Nucl Med. 2018 Jun;59(6):944-951
pubmed: 29191858
J Alzheimers Dis. 2018;62(4):1713-1724
pubmed: 29614676

Auteurs

Irene Sintini (I)

Department of Radiology, Mayo Clinic, Rochester, MN, USA. Electronic address: Sintini.Irene@mayo.edu.

Peter R Martin (PR)

Department of Health Science Research (Biostatistics), Mayo Clinic, Rochester, MN, USA.

Jonathan Graff-Radford (J)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Matthew L Senjem (ML)

Department of Radiology, Mayo Clinic, Rochester, MN, USA; Department of Information Technology, Mayo Clinic, Rochester, MN, USA.

Christopher G Schwarz (CG)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Mary M Machulda (MM)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Anthony J Spychalla (AJ)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Daniel A Drubach (DA)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Ronald C Petersen (RC)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Val J Lowe (VJ)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Clifford R Jack (CR)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Keith A Josephs (KA)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Jennifer L Whitwell (JL)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH